Here are four key notes:
1. Nevro is a medical device company developing spinal cord stimulators, including its proprietary Senza system.
2. The study will include up to 75 patients, of which 10 or 15 are patients of Richard H. Bundschu, MD, an interventional pain specialist with Coastal Orthopedics.
3. The study will evaluate the efficacy of Nevro’s spinal cord stimulators in treating chronic neck and arm pain.
4. Dr. Bundschu has worked with Nevro on two previous studies that helped the company’s products earn FDA approval.
More articles on devices:
Oxford Performance Materials’ SpineFab VBR gets FDA clearance — 5 key notes
FH Orthopedics becoming key player in European spine solutions market: 7 notes
Grand jury indicts troubled Texas spine surgeon — 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
